Skip to content

Fight Fatigue: A Progressive Muscle Relaxation and Walking Intervention to Reduce Fatigue in Adults With ESKD

Fight Fatigue: A Progressive Muscle Relaxation and Walking Intervention to Reduce Fatigue in Adults With ESKD

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07014111
Enrollment
40
Registered
2025-06-10
Start date
2025-09-02
Completion date
2027-06-01
Last updated
2026-09-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

End Stage Renal Disease on Dialysis

Keywords

Fatigue

Brief summary

Fight Fatigue is evaluating the feasibility and acceptability of a combined progressive muscle relaxation and walking intervention to reduce fatigue for adults with end-stage kidney disease receiving in-center hemodialysis.

Interventions

BEHAVIORALFight Fatigue

Combined progressive muscle relaxation and walking (increasing step count) 12-week intervention that consists of education/training followed by text messages.

OTHERAttention Control

End-stage kidney disease education

Sponsors

University of Illinois at Chicago
Lead SponsorOTHER
National Center for Complementary and Integrative Health (NCCIH)
CollaboratorNIH

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Diagnosis of ESKD diagnosis and receiving hemodialysis for at least 3 months * Can read and speak English * Fatigue measured via visual analogue scale, score ≥4 over the last week * Able to stand and walk one block * Has a cell phone that can receive text messages

Exclusion criteria

* Patient's nephrologist refuses for them to participate * Unstable angina * Unstable pulmonary disease or pulmonary symptoms that preclude participation * Lower-extremity amputation without prosthetic (BKA, AKA) -Orthopedic or neurologic condition that would preclude walking or tensing/releasing of muscles- * Cognitive impairment that, in the judgement of the research team, precludes trial participation * Participation in the formative phase of the development of Fight Fatigue

Design outcomes

Primary

MeasureTime frameDescription
Feasibility of recruitmentBaseline to week 12Recruitment metrics (enrolled/invited)
Feasibility of retentionBaseline to week 12Retention in the study from baseline to week 12
AcceptabilityEnd of study (Week 12)Participant rating of acceptability (e.g., enjoyable, easy to understand) via Likert scale questions and open ended questions
Adherence to the study protocolBaseline to week 12Adherence to the intervention measured with adherence to step counts, number/duration of accesses on the study-specific website, and adherence to study procedures as evaluated with number of text messages read/sent messages read.

Countries

United States

Contacts

CONTACTMary Hannan, PhD
mhanna22@uic.edu3123554838

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 3, 2026